| Literature DB >> 31586562 |
Anna Rzepakowska1, Michał Żurek2, Jakub Grzybowski3, Paweł Pihowicz3, Barbara Górnicka3, Ewa Osuch-Wójcikiewicz2, Kazimierz Niemczyk2.
Abstract
INTRODUCTION: The microarchitecture of the mucosal and submucosal vessels is crucial for diagnosis of vocal fold lesions. Neo-angiogenesis is a confirmed biological parameter that implicates progression and metastasis in laryngeal cancer.Entities:
Keywords: Dysplasia; Early glottis cancer; Intraepithelial lesion; Microvessel density; Narrow band imaging
Mesh:
Year: 2019 PMID: 31586562 PMCID: PMC9422362 DOI: 10.1016/j.bjorl.2019.07.009
Source DB: PubMed Journal: Braz J Otorhinolaryngol ISSN: 1808-8686
Figure 1Examples of H&E.
Demographical data and the NBI vascular patterns according to the Ni classification and European Laryngological Society (ELS) staging for individual histopathological lesion types.
| Number of lesions | Age mean ± SD | NBI Type I | NBI Type II | NBI Type III | NBI Type IV | NBI Type Va | NBI Type Vb | NBI Type Vc | ELS longitudinal | ELS perpendicular | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Non-dysplastic | 20 | 55.15 ± 12.38 | 1 | 19 | ‒ | ‒ | ‒ | ‒ | ‒ | 20 | ‒ |
| Low-grade dysplasia | 20 | 61.55 ± 10.66 | ‒ | 2 | 4 | 12 | 2 | ‒ | ‒ | 6 | 14 |
| High-grade dysplasia | 17 | 64.94 ± 11.25 | ‒ | ‒ | 1 | 1 | 6 | 6 | 3 | 1 | 16 |
| Invasive cancer | 20 | 66.65 ± 9.31 | ‒ | ‒ | ‒ | ‒ | 2 | 8 | 10 | ‒ | 20 |
| All lesions | 77 | 61.96 ± 11.62 | 1 | 21 | 5 | 13 | 10 | 14 | 13 | 27 | 50 |
The mean microvessel density (MVD) with CD31 in individual vascular pattern types according to the Ni and European Laryngological Society (ELS) classifications.
| NBI classification | Number of analyzed lesions | Mean CD31 MVD | Range of CD31 MVD | Standard deviation (±SD) CD31 MVD | Standard error CD31 MVD | 95% CI CD31 MVD | |
|---|---|---|---|---|---|---|---|
| Type I | 1 | 3.33 | ‒ | ‒ | ‒ | ‒ | ‒ |
| Type II | 21 | 12.63 | 3.00‒33.33 | 7.87 | 1.68 | 9.14‒16.11 | 0.04 |
| Type III | 5 | 12.73 | 5.33‒ 21.00 | 6.44 | 2.88 | 4.74‒ 20.73 | 0.115 |
| Type IV | 13 | 20.55 | 8.67‒ 56.00 | 13.95 | 3.73 | 12.49‒28.60 | 0.842 |
| Type Va | 10 | 17.67 | 5.67‒ 26.67 | 7.19 | 2.72 | 11.02‒24.32 | 0.198 |
| Type Vb | 14 | 19.67 | 6.00‒53.67 | 13.59 | 3.51 | 12.14‒27.19 | 0.16 |
| Type Vc | 13 | 19.92 | 9.00‒34.67 | 7.11 | 1.97 | 15.63‒24.22 | 0.013 |
| Total | 77 | 17.01 | 3.00‒56.00 | 10.63 | 1.21 | 14.60‒19.43 | 0.016 |
| ELS longitudinal pattern | 27 | 12.50 | 3.00‒33.33 | 7.65 | 1.47 | 9.47‒15.52 | 0.02 |
| ELS perpendicular pattern | 50 | 19.45 | 5.67‒56.00 | 11.27 | 1.59 | 16.25-22.65 |
95% CI, Confidence Interval 95%.
p-value of Mann-Whitney U test.
p-value of Kruskal-Wallis test.
Figure 2Graphical statistics for CD31 MVD (2A) and ELS classifications (2B).
The mean microvessel density (MVD) with CD34 in individual vascular pattern types according to the Ni and European Laryngological Society (ELS) classifications.
| NBI classification | Number of analyzed lesions | Mean CD34 MVD | Range of CD34 MVD | Standard deviation (±SD) CD34 MVD | Standard error CD34 MVD | 95% CI CD34 MVD | |
|---|---|---|---|---|---|---|---|
| Type I | 1 | 2.00 | ‒ | ‒ | ‒ | ‒ | ‒ |
| Type II | 21 | 15.30 | 3.40‒3180 | 9.47 | 2.02 | 11.10‒19.50 | <0.001 |
| Type III | 5 | 14.72 | 2.80‒25.40 | 8.82 | 3.97 | 3.69‒25.75 | 0.08 |
| Type IV | 13 | 25.94 | 7.60‒49.40 | 13.39 | 3.58 | 18.20‒33.68 | 0.153 |
| Type Va | 10 | 35.43 | 17.00‒57.40 | 16.14 | 6.10 | 20.50‒50.36 | 0.01 |
| Type Vb | 14 | 30.48 | 6.80‒56.00 | 12.49 | 3.27 | 23.56‒37.40 | 0.02 |
| Type Vc | 13 | 34.45 | 10.00‒92.60 | 20.54 | 5.70 | 22.04‒46.86 | 0.03 |
| Total | 77 | 25.04 | 2.00‒92.60 | 15.75 | 1.79 | 21.47‒28.62 | <0.001 |
| ELS longitudinal pattern | 27 | 15.12 | 2.00‒31.80 | 9.27 | 1.79 | 11.44‒18.90 | <0.001 |
| ELS perpendicular pattern | 50 | 30.40 | 4.00‒92.60 | 15.98 | 2.26 | 25.86‒ 39.44 |
95% CI, Confidence Interval 95%.
p-value of Mann-Whitney U test.
p-value of ANOVA.
Figure 3Graphical statistics for CD34 MVD (3A) and ELS classifications (3B).